Literature DB >> 6245765

Control of opiate receptor-adenylate cyclase interactions by calcium ions and guanosine-5'-triphosphate.

D Wilkening, S L Sabol, M Nirenberg.   

Abstract

Adenylate cyclase of homogenates of NG108-15 neuroblastoma x glioma hybrid cells is activated by low concentrations of Ca2+ ions and is inhibited by higher (greater than 0.1 mM) concentrations of Ca2+ ions. Activation of either opiate receptors by 10 microM morphine or alpha-adrenergic receptors by 10 microM norepinephrine inhibits adenylate cyclase by 55% in the absence of Ca2+ ions, and inhibits the Ca2+-dependent activation of adenylate cyclase by more than 90%. Concentrations of Ca2+ ions greater than 0.1 mM inhibit adenylate cyclase and also reduce the extent inhibition of adenylate cyclase by morphine but not by norepinephrine. Guanosine-5'-triphosphate (0.1-1 microM) is required for inhibition of adenylate cyclase by morphine. The results show that morphine inhibits adenylate cyclase by a guanosine-5-triphosphate-dependent process and that the extent of inhibition of adenylate cyclase by morphine or norepinephrine is a function of the Ca2+ ion concentration and the proportion of adenylate cyclase molecules that are activated or inhibited by Ca2+ ions.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6245765     DOI: 10.1016/0006-8993(80)90105-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  Regulation of adenylate cyclase type VIII splice variants by acute and chronic Gi/o-coupled receptor activation.

Authors:  Debora Steiner; Tomer Avidor-Reiss; Ester Schallmach; Elena Butovsky; Nirit Lev; Zvi Vogel
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

2.  Enhancement of delta- but not mu-opiate agonist binding by calcium.

Authors:  A Pfeiffer; A Herz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-05       Impact factor: 3.000

3.  Interconverting mu and delta forms of the opiate receptor in rat striatal patches.

Authors:  W D Bowen; S Gentleman; M Herkenham; C B Pert
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.